Some cardiovascular properties of prostacyclin (PGI2) which are not shared by PGE2.
D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects*; D002417:Cattle; D003326:Coronary Circulation / Q000187:drug effects; D004285:Dogs; D011464:Epoprostenol / Q000494:pharmacology*; D005260:Female; D005263:Femoral Artery / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008168:Lung / Q000098:blood supply; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects; D011453:Prostaglandins / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology*; D014628:Vagotomy; D014664:Vasodilation / Q000187:drug effects
D011453:Prostaglandins; D011458:Prostaglandins E; D011464:Epoprostenol